2021 - Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan
Topics/Call fo Papers
The Medical Device Single Audit Program (MDSAP)
Device Classification
Licensing Pathways
Medical Device GMP
Inspections
Device Labeling
License Holder Responsibilities
Timelines and Fees
Country Specific Cultural Considerations and Challenges
Adverse Event Reporting
Device Classification
Licensing Pathways
Medical Device GMP
Inspections
Device Labeling
License Holder Responsibilities
Timelines and Fees
Country Specific Cultural Considerations and Challenges
Adverse Event Reporting
Other CFPs
- Project Management in Accounting
- Integrating Design Controls and the Product Development Process for Effective and Compliant Medical Device Development
- The Fair Labor Standards Act (FLSA): Wage and Hour Compliance for 2022
- FinCEN's New CDD Rule - The New Fifth Prong of the AML
- GMP Environmental Monitoring for Pharmaceutical Clean Rooms
Last modified: 2021-10-30 03:53:58